Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Subcontract opportunity from Department Of Veterans Affairs was posted on August 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Pharmaceutical Prime Vendor (PPV) Distribution Services

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

This subcontract for Pharmaceutical Prime Vendor Distribution Services involves the logistics and distribution of pharmaceutical products for prime contractors supporting the Department of Veterans Affairs. The scope of work includes executing chargeback agreements with Pharmaceutical Prime Vendors to ensure efficient delivery to VA and DoD ordering activities. Operations are supported by B2B electronic data interchange systems for streamlined order processing, with final product delivery to government sites managed through the PPV network. The contract is associated with Nac Pharmaceuticals and is categorized under NAICS code 424210. Performance of these services is centered in Hines, Illinois. Interested parties should note the response deadline of September 4, 2026, following the posting date of August 28, 2026.

General Info

Nac Pharmaceuticals subcontract for VA pharmaceutical distribution services in Hines, Illinois.

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

Hines, IL, 60141

Set-Aside

NONE

Documents

This scope was carved out of 36E79726Q0004.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Droxidopa Capsules (VA-27-00007975)

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Performs logistics and distribution of pharmaceutical products for prime contractors on Department of Veterans Affairs (VA) contracts. Executes chargeback agreements with Pharmaceutical Prime Vendors (PPV) to facilitate distribution to VA/DoD ordering activities. Utilizes B2B electronic data interchange (EDI) systems for order processing. Delivers product to government sites via the PPV network.

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs is soliciting proposals for the procurement of Latanoprost 0.005% Ophthalmic Solution to ensure an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted commercial item procurement is structured into two groups, with one award made in the aggregate for either Group I (single bottles) or Group II (single and bulk cartons). The resulting contract will consist of a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to deliver supplies to designated distribution centers based on business-to-business agreements. Award will be granted based on the lowest evaluated price among proposals that meet all non-cost acceptability standards. Offerors must provide a unique 11-digit NDC number and adhere to the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Strict compliance with FDA current Good Manufacturing Practice standards is required, and offerors must certify they possess the necessary NDA, ANDA, or BLA approvals. Additionally, products must meet rigorous barcoding and serialization requirements under the Drug Supply Chain Security Act, including the use of GS-1 data matrix codes. Proposals must be submitted by November 17, 2026, and must include a 0.5% cost recovery fee embedded in the pricing.
Pharmaceutical Preparation Manufacturing

POSTED

11 days ago

DEADLINE

in 7 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS